Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0002079210-25-000003

Options or other derivatives

  • Chief Development Officer acquired 218,652 shares (grant or award)
  • Chief Development Officer returned 218,652 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zuraw Qing Che Chief Development Officer 2025-12-05 Returned to the company · Employee Stock Option (right to buy) −218,652 0 D
Zuraw Qing Che Chief Development Officer 2025-12-05 Grant or award · Employee Stock Option (right to buy) +218,652 218,652 D
Loading xslF345X05/form4-12092025_081203.xml…